Cargando…
Inner Retinal Changes in Acute Experimental BRVO Treated With Bevacizumab or Triamcinolone Acetonide
PURPOSE: Apoptosis is a key process in neural degeneration associated with retinal vascular diseases. Vascular endothelial growth factor (VEGF) antagonists, including bevacizumab, are used to treat macular edema in these diseases. As VEGF has a critical role in the preservation of retinal neuronal c...
Autores principales: | McAllister, Ian L., Vijayasekaran, Sarojini, Bhikoo, Riyaz, Chen, Fred K., Zhang, Dan, Kanagalingam, Emily, McLenachan, Samuel, Yu, Dao-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919627/ https://www.ncbi.nlm.nih.gov/pubmed/36753186 http://dx.doi.org/10.1167/tvst.12.2.11 |
Ejemplares similares
-
Safety Profile of Lutein- Versus Triamcinolone Acetonide–Based Vitreous Staining
por: Lazzara, Francesca, et al.
Publicado: (2023) -
Vessel Pulse Amplitude Mapping in Eyes With Central and Hemi Retinal Venous Occlusion
por: Khoo, Ying J., et al.
Publicado: (2023) -
Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration
por: Lynch, Stephanie K., et al.
Publicado: (2019) -
Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy
por: McAllister, Ian L, et al.
Publicado: (2021) -
Microperimetry and Adaptive Optics Imaging Reveal Localized Functional and Structural Changes in Asymptomatic RPGR Mutation Carriers
por: Roshandel, Danial, et al.
Publicado: (2023)